Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

ElectroCore's Vagus Nerve Stimulator Wins Breakthrough Device Tag For Stress Disorder

The FDA has granted Breakthrough Designation to ElectroCore Inc's (NASDAQ:ECOR) gammaCore nVNS device for posttraumatic stress disorder (PTSD).

  • The device showed a reduction of symptoms of PTSD by 31% when compared to sham.
  • Related: ElectroCore's Non-invasive Nerve Stimulator Effective Against Migraine.
  • GammaCore (nVNS) is the first non-invasive, hand-held medical therapy applied at the neck as adjunctive therapy to treat migraine and cluster headache by utilizing a mild electrical stimulation to the vagus nerve passes through the skin. 
  • Price Action: ECOR shares are up 20.4% at $0.65 during the market session on the last check Wednesday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.